By selectively binding to overexpressed receptors or proteins on cancer cells (e.g., EGFR, nucleolin, or PD-L1), high-affinity aptamers can facilitate targeted drug delivery or imaging [17]. This evidence concerns the gene NUCLEOLIN and cancer.